The Federal Laboratory Consortium (FLC) for Technology Transfer Mid-Atlantic Region is pleased to announce the following winners of its 2019 awards:
We are pleased to announce that Dr. Monica Lopez will receive from the President of Johns Hopkins University and the Johns Hopkins Alumni Association the prestigious Outstanding Recent Graduate Award for bringing credit to Johns Hopkins University through outstanding professional achievements, leadership, and vision.
Image: http://www.lpnproductions.com
GAITHERSBURG, Md., Oct. 03, 2019 (GLOBE NEWSWIRE) — Arcellx, a privately-held biopharmaceutical company, today announced that it has raised $85 million in an oversubscribed Series B financing. Proceeds will be used to advance the Company’s ARC-T + sparX programs, including clinical development of a bivalent BCMA-targeted cell therapy in multiple myeloma, and a CD123-targeted therapy in acute myeloid leukemia. The Series B will also fund earlier stage ARC-T + sparX programs for patients with solid tumors and diseases outside oncology.
Partnerships with consumer-tech firms could help medtech companies innovate and stay relevant as healthcare turns increasingly to prevention and wellness, according to a new report from Deloitte.
Executives at medtech companies may be leery of Apple and other consumer-technology companies, especially as the latter tout ever-more-sophisticated healthcare applications. But as healthcare evolves, those potential competitors may turn out to be good partners, according to a new report by accounting and consulting firm Deloitte.
GSK Opens $139M U.S. Expansion of Commercial Manufacturing Facility in Rockville, Maryland · BioBuzz
The ribbon was cut today at GSK’s recently expanded manufacturing facility in Rockville, marking the completion of a $139M project that was first announced in May 2017 to support growing demand for BENLYSTA® (belimumab), a treatment for adult patients with Lupus.
Image: https://biobuzz-io.cdn.ampproject.org
Gaithersburg’s Viela Bio Inc. began publicly trading Thursday on the Nasdaq.
The clinical-stage biotech is offering 7.9 million shares of common stock priced at $19 per share, positioning the company to raise roughly $150 million. Viela (NASDAQ: VIE) is also giving underwriters the option to buy up to an additional 1.19 million shares at the initial public offering price for 30 days.
Image: Viela Bio CEO Bing Yao and colleagues rang the opening Nasdaq bell Thursday. LIBBY GREENE
Kylene Kehn-Hall, Ph.D. carefully puts on her personal protective equipment (PPE) – a Tyvek suit, gloves, overshoes and a specialized helmet with a built-in respirator designed to protect the wearer from exposure to airborne pathogens. With an almost meditative vigilance, she periodically checks herself for any potential gaps or ruptures in the material—a necessary precaution when working with the Venezuelan equine encephalitis virus (VEEV).
Johns Hopkins University will host the DevLab XR Accelerator 2019 from Oct. 16 to Dec. 5 in an effort to support augmented reality projects created by those in underserved communities.
This year, virtual reality (VR) network Kaleidoscope, which organized the event, is partnering with Saul Zaentz Innovation Fund at JHU and immersive media company RYOT in order to expand the outreach of the program.
Image: VR at MICA Game Lab’s Fall Arcade. (Photo by Stephen Babcock) – https://technical.ly
You and your company team will be competing against other biotech firms to win the coveted BioBowl Trophy and bragging rights!
…Until next year
Date: Thursday, October 10th, 2019 Time: 4:00 – 6:30 PM (TBC) Location: Bowlmor – 15720 Shady Grove Rd, Gaithersburg, MD 20877
Invitation to follow.
Hosted by BioHealth Innovation and AstraZeneca
“Top 3 By 2023” has been the slogan for the Biohealth Capital Region (BHCR) over the past few years adopted by many economic development and industry leaders across Maryland, DC, and Virginia.
After more than four years of organized effort across the BHCR, starting with the first Regional Biotech Forum back in 2015, there is a clearly defined strategy underway and substantial progress is being made towards achieving that goal.